Atlas Trials

Refractory Nasopharyngeal Carcinoma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Refractory Nasopharyngeal Carcinoma

RecordFirmDate
Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma (NCT00484601)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2004-04-15

Track Refractory Nasopharyngeal Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.